Zobrazeno 1 - 10
of 1 645
pro vyhledávání: '"Paul, Emery"'
Autor:
Jeffrey A. Sparks, Philippe Dieudé, Anna-Maria Hoffmann-Vold, Gerd R Burmester, Simon LF Walsh, Michael Kreuter, Christian Stock, Steven Sambevski, Margarida Alves, Paul Emery
Publikováno v:
BMC Rheumatology, Vol 8, Iss 1, Pp 1-9 (2024)
Abstract Background Patients with rheumatoid arthritis (RA) are at risk of developing interstitial lung disease (ILD), which is associated with high mortality. Screening tools based on risk factors are needed to decide which patients with RA should b
Externí odkaz:
https://doaj.org/article/7f168e26c2354e6d9a2a6c55793ae5b1
Autor:
Hanna Gul, Andrea Di Matteo, Innocent Anioke, Farag Shuweidhi, Kulveer Mankia, Frederique Ponchel, Paul Emery
Publikováno v:
ACR Open Rheumatology, Vol 6, Iss 5, Pp 294-303 (2024)
Objective The tapering of biologic disease‐modifying antirheumatic drug (b‐DMARD) therapy for patients with rheumatoid arthritis (RA) in stable remission is frequently undertaken, but specific guidance on how to successfully taper is lacking. The
Externí odkaz:
https://doaj.org/article/e593e4f49c6640ee8394d6f0da713589
Autor:
Catherine Hewitt, Abhishek Abhishek, Paul Emery, Laura Mandefield, Amar Rangan, Helena Marzo-Ortega, Joy Adamson, Johanna Taylor, Susan Shepherd, Sarah Ronaldson, Jeremy Mark Wilkinson, Laura Coates, Bernard Van Duren, James Maxwell, Hemant Pandit, Jagdeep Nanchahal, Jinshuo Li, Duncan Richards, Samantha Brady, Andrew Mott, Katie Carlisle, Susan Marion Goodman, Gillian Parkinson, Kulveer Singh Mankia
Publikováno v:
BMJ Open, Vol 14, Iss 6 (2024)
Introduction Biological disease-modifying antirheumatic drugs (bDMARDs) have revolutionised the treatment of inflammatory arthritis (IA). However, many people with IA still require planned orthopaedic surgery to reduce pain and improve function. Curr
Externí odkaz:
https://doaj.org/article/fd658c2b0bbd467bb464221453418580
Autor:
Jeffrey R. Curtis, Paul Emery, Bryan Downie, Yan Zhong, Jinfeng Liu, Ling Han, Rachael E. Hawtin, Gerd Rüdiger Burmester
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 1, Pp 177-189 (2023)
Abstract Objectives To assess cigarette smoking’s effects on efficacy of the preferential Janus kinase (JAK) 1 inhibitor filgotinib and drug persistence in patients with rheumatoid arthritis (RA). Methods Efficacy in non-smokers, former smokers, an
Externí odkaz:
https://doaj.org/article/e8bc03cbee46488dacc4d9c58186f5de
Autor:
Kulveer Mankia, Paul Emery, Michael Mahler, Andrea Di Matteo, Laurence Duquenne, Leticia Garcia-Montoya, Jacqueline L Nam, Sana Sharrack
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Objectives To investigate the role of third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in predicting progression to inflammatory arthritis (IA) in individuals with new musculoskeletal (MSK) symptoms and a negative second-gener
Externí odkaz:
https://doaj.org/article/be807a6bd0b64f99afddc81d26a2bb80
Autor:
Richard J Wakefield, Paul Emery, Helena Marzo-Ortega, Dennis G McGonagle, Ai Lyn Tan, Andrea Di Matteo, Philip Helliwell, Gabriele De Marco, Or Hen, Sayam R Dubash
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Aims To investigate the prevalence and distribution of bone erosions in an early psoriatic arthritis (PsA) population using conventional radiography (CR) and to explore the agreement between CR and ultrasound (US) detected bone erosions.Methods Newly
Externí odkaz:
https://doaj.org/article/15f487623a5440dbaab3cb86594c7238
Autor:
Paul Emery, Yoshiya Tanaka, Vivian P. Bykerk, Clifton O. Bingham, Thomas W. J. Huizinga, Gustavo Citera, Kuan-Hsiang Gary Huang, Chun Wu, Sean E. Connolly, Yedid Elbez, Robert Wong, Karissa Lozenski, Roy Fleischmann
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-13 (2023)
Abstract Background AVERT-2 (a phase IIIb, two-stage study) evaluated abatacept + methotrexate versus methotrexate alone, in methotrexate-naive, anti-citrullinated protein antibody-positive patients with early (≤ 6 months), active RA. This subanaly
Externí odkaz:
https://doaj.org/article/6d0a8a1b51f94829ba8345f63f12219d
Autor:
Paul Emery, Yoshiya Tanaka, Vivian P. Bykerk, Thomas W. J. Huizinga, Gustavo Citera, Clifton O. Bingham, Subhashis Banerjee, Benjamin P. Soule, Marleen Nys, Sean E. Connolly, Karissa L. Lozenski, Joe Zhuo, Robert Wong, Kuan-Hsiang Gary Huang, Roy Fleischmann
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 3, Pp 707-727 (2023)
Abstract Introduction One target of rheumatoid arthritis (RA) treatment is to achieve early sustained remission; over the long term, patients in sustained remission have less structural joint damage and physical disability. We evaluated Simplified Di
Externí odkaz:
https://doaj.org/article/031a80a1de6645ab8805525b4951051a
Autor:
Klara Martinsson, Andrea Di Matteo, Carina Öhman, Anders Johansson, Anna Svärd, Kulveer Mankia, Paul Emery, Alf Kastbom
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
ObjectivesPeriodontitis and underlying bacteria have been linked to the development of rheumatoid arthritis (RA). One suggested pathogen is Aggregatibacter actinomycetemcomitans (A.a.), which expresses leukotoxin A (LtxA) that can citrullinate human
Externí odkaz:
https://doaj.org/article/b0a8ea4d2ac0491fa06ac9120bb75967
Autor:
Michael Kreuter, Marco Matucci-Cerinic, Yannick Allanore, Dinesh Khanna, Paul Emery, Gerd R Burmester, Janet Pope, Philippe Dieude, Eric L. Matteson
Publikováno v:
RMD Open, Vol 9, Iss 3 (2023)
Objective Interstitial lung disease (ILD) is an important cause of mortality in some patients with rheumatoid arthritis (RA). Patient-level factors may predict which patients with RA are at the highest risk of developing ILD and are therefore candida
Externí odkaz:
https://doaj.org/article/d5c3e40869f640589055cfc4f50b707d